Abstract

B cells and T cells collaborate in multiple sclerosis (MS) pathogenesis. IgH[MOG] mice possess a B cell repertoire skewed to recognize myelin oligodendrocyte glycoprotein (MOG). Here, we show that upon immunization with the T cell-obligate autoantigen, MOG[35-55], IgH[MOG] mice develop rapid and exacerbated experimental autoimmune encephalomyelitis (EAE) relative to wildtype (WT) counterparts, characterized by aggregation of T and B cells in the IgH[MOG] meninges and by CD4+ T helper 17 (Th17) cells in the CNS. Production of the Th17 maintenance factor IL-23 is observed from IgH[MOG] CNS-infiltrating and meningeal B cells, and in vivo blockade of IL-23p19 attenuates disease severity in IgH[MOG] mice. In the CNS parenchyma and dura mater of IgH[MOG] mice, we observe an increased frequency of CD4+PD-1+CXCR5- T cells that share numerous characteristics with the recently described T peripheral helper (Tph) cell subset. Further, CNS-infiltrating B and Tph cells from IgH[MOG] mice show increased reactive oxygen species (ROS) production. Meningeal inflammation, Tph-like cell accumulation in the CNS and B/Tph cell production of ROS were all reduced upon p19 blockade. Altogether, MOG-specific B cells promote autoimmune inflammation of the CNS parenchyma and meninges in an IL-23-dependent manner.

B cells are crucial in multiple sclerosis (MS) pathology but the mechanisms are incompletely understood. In a mouse model of MS, the authors show that B cells make IL-23, and that IL-23 invokes meningeal inflammation and CNS presence of T peripheral helper cells.

Details

Title
Myelin-reactive B cells exacerbate CD4+ T cell-driven CNS autoimmunity in an IL-23-dependent manner
Author
Fazazi, Mohamed Reda 1 ; Doss, Prenitha Mercy Ignatius Arokia 1 ; Pereira, Resel 2 ; Fudge, Neva 3 ; Regmi, Aryan 4 ; Joly-Beauparlant, Charles 5 ; Akbar, Irshad 1 ; Yeola, Asmita Pradeep 1 ; Mailhot, Benoit 1 ; Baillargeon, Joanie 1 ; Grenier, Philippe 5 ; Bertrand, Nicolas 6 ; Lacroix, Steve 7 ; Droit, Arnaud 8   VIAFID ORCID Logo  ; Moore, Craig S. 3   VIAFID ORCID Logo  ; Rojas, Olga L. 4   VIAFID ORCID Logo  ; Rangachari, Manu 7   VIAFID ORCID Logo 

 Centre de recherche du Centre hospitalier universitaire (CHU) de Québec – Université Laval, Pavillon CHUL, axe Neurosciences, Quebec City, Canada (GRID:grid.411081.d) (ISNI:0000 0000 9471 1794) 
 University Health Network, Krembil Research Institute, Toronto, Canada (GRID:grid.231844.8) (ISNI:0000 0004 0474 0428) 
 Memorial University of Newfoundland, Division of BioMedical Sciences, St. John’s, Canada (GRID:grid.25055.37) (ISNI:0000 0000 9130 6822); Memorial University of Newfoundland, Department of Neurology, Faculty of Medicine, St. John’s, Canada (GRID:grid.25055.37) (ISNI:0000 0000 9130 6822) 
 University Health Network, Krembil Research Institute, Toronto, Canada (GRID:grid.231844.8) (ISNI:0000 0004 0474 0428); University of Toronto, Department of Immunology, Toronto, Canada (GRID:grid.17063.33) (ISNI:0000 0001 2157 2938) 
 Centre de recherche du Centre hospitalier universitaire (CHU) de Québec – Université Laval, Pavillon CHUL, axe Endocrinologie et nephrologie, Quebec City, Canada (GRID:grid.411081.d) (ISNI:0000 0000 9471 1794) 
 Centre de recherche du Centre hospitalier universitaire (CHU) de Québec – Université Laval, Pavillon CHUL, axe Endocrinologie et nephrologie, Quebec City, Canada (GRID:grid.411081.d) (ISNI:0000 0000 9471 1794); Laval University, Faculty of Pharmacy, Quebec City, Canada (GRID:grid.23856.3a) (ISNI:0000 0004 1936 8390) 
 Centre de recherche du Centre hospitalier universitaire (CHU) de Québec – Université Laval, Pavillon CHUL, axe Neurosciences, Quebec City, Canada (GRID:grid.411081.d) (ISNI:0000 0000 9471 1794); Laval University, Department of Molecular Medicine, Faculty of Medicine, Quebec City, Canada (GRID:grid.23856.3a) (ISNI:0000 0004 1936 8390) 
 Centre de recherche du Centre hospitalier universitaire (CHU) de Québec – Université Laval, Pavillon CHUL, axe Endocrinologie et nephrologie, Quebec City, Canada (GRID:grid.411081.d) (ISNI:0000 0000 9471 1794); Laval University, Department of Molecular Medicine, Faculty of Medicine, Quebec City, Canada (GRID:grid.23856.3a) (ISNI:0000 0004 1936 8390) 
Pages
5404
Publication year
2024
Publication date
2024
Publisher
Nature Publishing Group
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
3072375707
Copyright
© The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.